General
TGA chief says investigations likely to reveal more details about ‘atypical’ blood-clotting death
The head of the Therapeutic Goods Administration says an autopsy and review may reveal further information about a woman’s death from blood clotting likely linked to the AstraZeneca vaccine.
Key points:
- Professor Skerritt said the woman’s death was an “atypical” case
- The TGA said on Friday the fatal blood clotting was likely linked to the AstraZeneca vaccine
- The federal government is asking health authorities to continuously review all vaccines in the wake of the death
The 48-year-old woman from the New South Wales Central Coast had underlying health conditions but died in hospital several days after receiving the vaccine.
She received the AstraZeneca vaccine before authorities changed their advice to say people aged under 50 should…
-
General15 hours agoHungarian British author David Szalay wins Booker Prize 2025 for his novel Flesh
-
Business19 hours agoIf a 40-year-old invests $1,000 a month in ASX stocks, here’s how much they could have by retirement
-
Business10 hours agoMonash IVF has named a new Managing Director to help right the ship
-
General18 hours agoMillennials and Gen Z voters continued shift away from Coalition in 2025